Advertisement
Advertisement
U.S. markets close in 3 hours 43 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.5800-0.0100 (-0.63%)
As of 12:16PM EDT. Market open.
Advertisement

Amarin Corporation plc

Grand Canal Docklands
Block C 77 Sir John Rogerson's Quay
Dublin 2
Ireland
353 1 669 9020
https://www.amarincorp.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees560

Key Executives

NameTitlePayExercisedYear Born
Mr. Karim MikhailPres, CEO & Director1.19MN/A1971
Dr. Steven B. Ketchum Ph.D.Pres of R&D, Exec. VP and Chief Scientific Officer827.62k2.53M1965
Mr. Jason M. Marks J.D.Exec. VP, Chief Legal and Compliance Officer & Corp. Sec.626.07kN/A1976
Mr. Joseph T. Kennedy J.D.Exec. VP of Strategic Initiatives & Gen. Counsel980.18kN/A1968
Mr. Aaron D. BergExec. VP & Pres of U.S.745.52kN/A1963
Mr. Thomas Charles ReillyCFO & Sr. VPN/AN/A1972
Dr. David KeenanSr. VP of Technical OperationsN/AN/AN/A
Ms. Lisa M. DeFrancescoSr. VP of Corp. Affairs & Investor RelationsN/AN/A1980
Alina KolomeyerDirector of CommunicationsN/AN/AN/A
Mr. Jordan ZwickSr. VP of Corp. Bus. Devel.N/AN/A1987
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Corporate Governance

Amarin Corporation plc’s ISS Governance QualityScore as of July 1, 2022 is 7. The pillar scores are Audit: 8; Board: 6; Shareholder Rights: 7; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement